Mortality and morbidity in transsexual subjects treated with cross-sex hormones

Clinical Endocrinology

Volumn 47, Issue 3, 1997, Pages 337-343

  Van Kesteren, Paul J M ^a   Asscheman, Henk ^a   Megens, Jos A J ^a   Gooren, Louis J G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; PROLACTIN; TESTOSTERONE ESTER; TESTOSTERONE UNDECANOATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; CANCER INCIDENCE; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; THROMBOEMBOLISM; TRANSSEXUALISM;

EID: 0030809728     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2601068.x     Document Type: Article

References (33)

1. Asscheman, H., Gooren, L.J.G., Assies, J., Smits, J.P. & de Siegte, R. (1988) Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals. Clinical Endocrinology (Oxford), 28, 583-588.
2. Asscheman, H., Gooren, L.J.G. & Eklund, P.L. (1989) Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism, 38, 869-873.
3. Asscheman, H. & Gooren, L.J.G. (1992) Hormone treatment in transsexuals. Journal of Psychology and Human Sexuality, 5, 39-54.
4. Asscheman, H., Gooren, L.J.G., Megens, J.A., Nauta, J., Kloosterboer, H.J. & Eikelboom, F. (1994) Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol. Metabolism, 43, 935-939.
5. Barradell, L.B. & Faulds, D. (1994) Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer. Drugs and Aging, 5, 59-80.
6. Bell, J.I., Bishop, M.C. & Britton, B.J. (1977) Haemoperitoneum in a transsexual. Lancet, ii, 817.
7. Biller, J. & Saver, J.L. (1995) Ischemic cerebrovascular disease and hormone therapy for infertility and transsexualism. Neurology, 45, 1611-1613.
8. Coombes, G.B., Reiser, J., Paradinas, F.J. & Burn, I. (1978) An androgen associated hepatic adenoma in a trans-sexual. British Journal of Surgery, 65, 869-870.
9. Damewood, M.D., Bellantoni, J.J., Bachorik, P.S., Kimball, A.W.J. & Rock, J.A. (1989) Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males. Journal of Endocrinology Investigation, 12, 449-454.
10. DeMarinis, M. & Arnett, E.N. (1978) Cerebrovascular occlusion in a transsexual man taking mestranol. Annals of Internal Medicine, 138, 1372-1373.
11. Ganly, I. & Taylor, E.W. (1995) Breast cancer in a trans-sexual man receiving hormone replacement therapy. British Journal of Surgery, 82, 341.
12. Gardner, M.J. & Altman, D.F.G. (1989) Statistics With Confidence. British Medical Journal, London.
13. Gooren, L.J.G., Assies, J., Asscheman, H., de Siegte, R. & Van Kessel, H. (1988) Estrogen-induced prolactinoma in a man. Journal of Clinical Endocrinology and Metabolism, 66, 444-446.
14. Hoogendoorn, D. (1988) [Remarkable changes in the epidemiological pattern of gallstone disease and gallbladder cancer]. Nederlands Tijdschrift voor Geneeskunde, 132, 1243-1248.
15. Hoogendoorn, D. (1985) [Atherosclerotic brain disorders in the hospital and in the national statistics of cause of death; the cerebrovascular accident (CVA)]. Nederlands Tijdschrift voor Geneeskunde, 129, 1883-1887.
16. Kovacs, K., Stefaneanu, L., Ezzat, S. & Smyth, H.S. (1994) Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study. Archives of Pathology and Laboratory Medicine, 118, 562-565.
17. Kuiper, B. & Cohen-Kettenis, P. (1988) Sex reassignment surgery: a study of 141 Dutch transsexuals. Archives of Sexual Behaviour, 17, 439-457.
18. Markland, C. (1975) Transsexual surgery. Annals of Obstetrics and Gynecology, 4, 209-220.
19. Meyer, W.J., Webb, A., Stuart, C.A., Finkelstein, J.W., Lawrence, B. & Walker, P.A. (1986) Physical and hormonal evaluation of transsexual patients: a longitudinal study. Archives of Sexual Behaviour, 15, 121-138.
20. Miyai, K., Ichihara, K., Kondo, K. & Mon, S. (1986) Asymptomatic hyperprolactinaemia and prolactinoma in the general population - mass screening by paired assays of serum prolactin. Clinical Endocrinology (Oxford), 25, 549-554.
21. Netherlands Central Bureau of Statistics: Statistical Yearbook (1995) The Hague: SDU.
22. Pfäfflin, F. & Junge, A. (1992) Geschlechtsumwandlung. Schattauer, Stuttgart.
23. Polderman, K.H., Stehouwer, C.D., Van Kamp, G.J., Dekker, G.A., Verbeugt, F.W. & Gooren, L.J.G. (1993) Influence of sex hormones on plasma endothelin levels. Annals of Internal Medicine, 118, 429-432.
24. Polderman, K.H., Gooren, L.J.G., Asscheman, H., Bakker, A. & Heine, R.J. (1994) Induction of insulin resistance by androgens and estrogens. Journal of Clinical Endocrinology and Metabolism, 79, 265-271.
25. Reitsma, J.B. (ed.) (1995) Cardiovascular diseases in the Netherlands. Dutch Heart Association, The Hague.
26. Stadel, B.V. (1981) Oral contraceptives and cardiovascular disease. New England Journal of Medicine, 305, 612-618, 672-677.
27. Symmers, W. St C. (1968) Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. British Medical Journal, 2, 83-85.
28. The Coronary Drug Project (1973) Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group. JAMA, 226, 652-657.
29. Thurston, A.V. (1994) Carcinoma of the prostate in a transsexual. British Journal of Urology, 73, 217.
30. Van Kesteren, P.J.M., Meinhardt, W., Van der Valk, P., Geldof, A.A., Megens, J.A.J. & Gooren, L.J.G. (1996) Effects of estrogens only on the prostate of aging males. Journal of Urology, 156, 1349-1353.
31. Walker, P.A., Berger, J.C., Green, R., Laub, D.R., Reynolds, C.L. & Wollman, L. (1985) Standards of care. The hormonal and surgical sex reassignment of gender dysphoric persons. Archives of Sexual Behaviour, 14, 79-90.
32. Watanabe, S., Yamasaki, S., Tanae, A., Hibi, I. & Honna, T. (1994) There cases of hepatocellular carcinoma among cyproterone users. Ad hoc Committee on Androcur Users [letter]. Lancet, 344, 1567-1568.
33. Westaby, D., Ogle, S.J., Paradinas, F.J., Randell, J.B. & Murray Lyon, I.M. (1977) Liver damage from long-term methyltestosterone. Lancet, 2, 262-263.